https://orcid.org/0000-0002-9110-220X
References
- Rivers E, Nguyen B, Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–1377. doi:10.1056/NEJMoa010307
- Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063–e1143. doi:10.1097/CCM.0000000000005337
- Egi M, Ogura H, Yatabe T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020). J Intensive Care. 2021;9(1):53. doi:10.1186/s40560-021-00555-7
- Kobayashi M, Asakura R, Ehama Y, et al. Impact of anticoagulant therapy on mortality for sepsis-associated disseminated intravascular coagulation depending on the source of infection. J Intensive Crit Care. 2021;7(3):62. doi:10.36648/2471-8505.21.7.37
- Ogura T, Eguchi T, Nakahara K, et al. Clinical impact of recombinant thrombomodulin administration on disseminated intravascular coagulation due to severe acute cholangitis (Recover-AC study). J Hepatobiliary Pancreat Sci. 2023;30(2):221–228. doi:10.1002/jhbp.998
- Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):31–40. doi:10.1002/jhbp.509
- Tarasawa K, Fujimori K, Fushimi K. Recombinant human soluble thrombomodulin contributes to a reduction in-hospital mortality of acute cholangitis with disseminated intravascular coagulation: a propensity score analyses of a Japanese nationwide database. Tohoku J Exp Med. 2020;252(1):53–61. doi:10.1620/tjem.252.53
- Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
- Gando S, Saitoh D, Ogura H, et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med. 2008;36(1):145–150.
- Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829. doi:10.1097/00003246-198510000-00009
- Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22:707–710. doi:10.1007/BF01709751
- Kiriyama S, Takada T, Hwang TL, et al. Clinical application and verification of the TG13 diagnostic and severity grading criteria for acute cholangitis: an international multicenter observational study. J Hepatobiliary Pancreat Sci. 2017;24(6):329–337. doi:10.1002/jhbp.458
- van der Merwe SW, van Wanrooij RLJ, Bronswijk M, et al. Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2022;54(2):185–205. doi:10.1055/a-1717-1391
- Yamakawa K, Umemura Y, Hayakawa M, et al. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan. Crit Care. 2016;20:229. doi:10.1186/s13054-016-1415-1
- Kobayashi M, Ehama Y, Hirayama S. The Necessity of Individualized Treatment for Sepsis-Associated Disseminated Intravascular Coagulation by Infected Organ. Open Access Emerg Med. 2022;14:133–140. doi:10.2147/OAEM.S359216